We are pleased to announce a partnership with Catalent, Inc., a global contract development and manufacturing organization (CDMO) supporting pharmaceutical, biotech and consumer health companies across the full product lifecycle.
Catalent works with partners to develop, manufacture and launch a broad range of therapies, with a focus on quality, reliability and patient impact. Its services span early development through to commercial manufacturing, tailored to the specific needs of each program and stage. With a global network of more than 40 sites and thousands of scientists and technicians, Catalent supports the delivery of billions of doses of medicines each year.
Through this partnership, we aim to strengthen access to manufacturing expertise and industry know-how, supporting innovators as they advance therapies from development toward patients.
For more information about Catalent, click here.
